Ligand Pharmaceuticals
LGND
LGND
385 hedge funds and large institutions have $6.66B invested in Ligand Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 101 increasing their positions, 168 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
9.88% less ownership
Funds ownership: 194.61% → 184.72% (-9.9%)
23% less funds holding in top 10
Funds holding in top 10: 13 → 10 (-3)
40% less repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 168
Holders
385
Holding in Top 10
10
Calls
$59.9M
Puts
$28.8M
Top Buyers
| 1 | +$63.3M | |
| 2 | +$40.4M | |
| 3 | +$26.4M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$26.4M |
| 5 |
BlackRock
New York
|
+$22.4M |
Top Sellers
| 1 | -$98.9M | |
| 2 | -$49.2M | |
| 3 | -$39.7M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$33.2M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
-$29.3M |